Pegademase bovine (PEG-ADA) for the treatment of infants and children with severe combined immunodeficiency (SCID

por Claire Booth, H Bobby Gaspar
Publicado 2009

Development of gene therapy: potential in severe combined immunodeficiency due to adenosine deaminase deficiency

por Claudia A Montiel-Equihua, Adrian J Thrasher, H Bobby Gaspar
Publicado 2009

Metabolite and thymocyte development defects in ADA-SCID mice receiving enzyme replacement therapy

por Federico A. Moretti, Giuliana Giardino, Teresa C. H. Attenborough, Athina Soragia Gkazi, Ben K. Margetts, Giancarlo la Marca, Lynette Fairbanks, Tessa Crompton, H. Bobby Gaspar
Publicado 2021

Long-term lymphoid progenitors independently sustain naïve T and NK cell production in humans

por Natalia Izotova, Christine Rivat, Cristina Baricordi, Elena Blanco, Danilo Pellin, Eleanor Watt, Athina S. Gkazi, Stuart Adams, Kimberly Gilmour, Jinhua Bayford, Claire Booth, H. Bobby Gaspar, Adrian J. Thrasher, Luca Biasco
Publicado 2021

Molecular pathogenesis of EBV susceptibility in XLP as revealed by analysis of female carriers with heterozygous expression of SAP.

por Umaimainthan Palendira, Carol Low, Anna Chan, Andrew D Hislop, Edwin Ho, Tri Giang Phan, Elissa Deenick, Matthew C Cook, D Sean Riminton, Sharon Choo, Richard Loh, Frank Alvaro, Claire Booth, H Bobby Gaspar, Alessandro Moretta, Rajiv Khanna, Alan B Rickinson, Stuart G Tangye
Publicado 2011